Breath Test Technology Shows Promise for Early Lung Cancer Detection
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Lung Cancer |
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Oct 30, 2025 | Digital Pathology |
Market research projects 17.15% compound annual growth rate driven by AI integration and cloud-based platforms.
Read MorePosted by CLP Edit Staff | Oct 28, 2025 | Dementias & Alzheimer’s |
Roche’s Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Cancer |
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read MorePosted by CLP Edit Staff | Oct 15, 2025 | Melanoma |
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology’s most diverse specialties.
Read More